Multicenter prospective longitudinal study in 34 patients with Dravet syndrome: Neuropsychological development in the first six years of life.


Journal

Brain & development
ISSN: 1872-7131
Titre abrégé: Brain Dev
Pays: Netherlands
ID NLM: 7909235

Informations de publication

Date de publication:
Mar 2021
Historique:
received: 26 08 2018
revised: 27 09 2020
accepted: 12 10 2020
pubmed: 23 1 2021
medline: 5 10 2021
entrez: 22 1 2021
Statut: ppublish

Résumé

The objective of this study was to identify developmental trajectories of developmental/behavioral phenotypes and possibly their relationship to epilepsy and genotype by analyzing developmental and behavioral features collected prospectively and longitudinally in a cohort of patients with Dravet syndrome (DS). Thirty-four patients from seven Italian tertiary pediatric neurology centers were enrolled in the study. All patients were examined for the SCN1A gene mutation and prospectively assessed from the first years of life with repeated full clinical observations including neurological and developmental examinations. Subjects were found to follow three neurodevelopmental trajectories. In the first group (16 patients), an initial and usually mild decline was observed between the second and the third year of life, specifically concerning visuomotor abilities, later progressing towards global involvement of all abilities. The second group (12 patients) showed an earlier onset of global developmental impairment, progressing towards a generally worse outcome. The third group of only two patients ended up with a normal neurodevelopmental quotient, but with behavioral and linguistic problems. The remaining four patients were not classifiable due to a lack of critical assessments just before developmental decline. The neurodevelopmental trajectories described in this study suggest a differential contribution of neurobiological and genetic factors. The profile of the first group, which included the largest fraction of patients, suggests that in the initial phase of the disease, visuomotor defects might play a major role in determining developmental decline. Early diagnosis of milder cases with initial visuomotor impairment may therefore provide new tools for a more accurate habilitation strategy.

Identifiants

pubmed: 33478845
pii: S0387-7604(20)30282-5
doi: 10.1016/j.braindev.2020.10.004
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

419-430

Informations de copyright

Copyright © 2020 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.

Auteurs

Domenica Battaglia (D)

Child Neuropsychiatry Unit, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome, Italy; Università Cattolica del Sacro Cuore, Rome, Italy.

Daniela Chieffo (D)

Child Neuropsychiatry Unit, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome, Italy.

Simona Lucibello (S)

Università Cattolica del Sacro Cuore, Rome, Italy.

Carla Marini (C)

Child Neurology Unit, Pediatric Hospital A. Meyer, University of Florence, Italy.

Valentina Sibilia (V)

Child Neurology Unit, Pediatric Hospital A. Meyer, University of Florence, Italy.

Davide Mei (D)

Child Neurology Unit, Pediatric Hospital A. Meyer, University of Florence, Italy.

Francesca Darra (F)

Child Neuropsychiatry Unit, University of Verona, Italy.

Francesca Offredi (F)

Child Neuropsychiatry Unit, University of Verona, Italy.

Elena Fontana (E)

Child Neuropsychiatry Unit, University of Verona, Italy.

Nicola Specchio (N)

Neurology Department, Bambino Gesù Children's Hospital, Rome, Italy.

Simona Cappelletti (S)

Psychology Unit, Bambino Gesù Children's Hospital, Rome, Italy; Neurology Department, Bambino Gesù Children's Hospital, Rome, Italy.

Tiziana Granata (T)

Department of Pediatric Neuroscience, IRCCS Foundation Neurological Institute C. Besta, Milan, Italy.

Francesca Ragona (F)

Department of Pediatric Neuroscience, IRCCS Foundation Neurological Institute C. Besta, Milan, Italy.

Mara Patrini (M)

Department of Pediatric Neuroscience, IRCCS Foundation Neurological Institute C. Besta, Milan, Italy.

Maria G Baglietto (MG)

Child Neuropsychiatry Unit, IRCCS Gaslini, University of Genoa, Italy.

Giulia Prato (G)

Child Neuropsychiatry Unit, IRCCS Gaslini, University of Genoa, Italy.

Annarita Ferrari (A)

IRCCS Stella Maris, University of Pisa, Italy.

Federico Vigevano (F)

Psychology Unit, Bambino Gesù Children's Hospital, Rome, Italy; Neurology Department, Bambino Gesù Children's Hospital, Rome, Italy.

Eugenio Mercuri (E)

Child Neuropsychiatry Unit, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome, Italy; Università Cattolica del Sacro Cuore, Rome, Italy.

Bernardo Dalla Bernardina (BD)

Child Neuropsychiatry Unit, University of Verona, Italy.

Renzo Guerrini (R)

Child Neurology Unit, Pediatric Hospital A. Meyer, University of Florence, Italy.

Charlotte Dravet (C)

Child Neuropsychiatry Unit, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome, Italy; Università Cattolica del Sacro Cuore, Rome, Italy. Electronic address: charlotte.dravet@free.fr.

Francesco Guzzetta (F)

Università Cattolica del Sacro Cuore, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH